Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Elucidation of the time course of adenosine deaminase APOBEC3G and viral infectivity factor vif in HIV-2(287) -infected infant macaques.

Endsley AN, Ho RJ.

J Med Primatol. 2012 Feb;41(1):52-9. doi: 10.1111/j.1600-0684.2011.00518.x. Epub 2011 Oct 24.

2.

Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.

Ao Z, Yu Z, Wang L, Zheng Y, Yao X.

PLoS One. 2008 Apr 16;3(4):e1995. doi: 10.1371/journal.pone.0001995.

3.

The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.

Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A.

J Exp Med. 2010 Jan 18;207(1):39-49. doi: 10.1084/jem.20091933. Epub 2009 Dec 28.

4.

Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Thippeshappa R, Polacino P, Yu Kimata MT, Siwak EB, Anderson D, Wang W, Sherwood L, Arora R, Wen M, Zhou P, Hu SL, Kimata JT.

J Virol. 2011 Apr;85(8):3767-79. doi: 10.1128/JVI.02438-10. Epub 2011 Feb 2.

5.

Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count.

Bizinoto MC, Yabe S, Leal É, Kishino H, Martins Lde O, de Lima ML, Morais ER, Diaz RS, Janini LM.

BMC Infect Dis. 2013 Apr 11;13:173. doi: 10.1186/1471-2334-13-173.

6.

Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.

Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K.

Retrovirology. 2007 Aug 29;4:61.

7.

Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.

De Pasquale M, Kourteva Y, Allos T, D'Aquila RT.

PLoS One. 2013 Oct 16;8(10):e76002. doi: 10.1371/journal.pone.0076002. eCollection 2013.

8.

APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.

Kourteva Y, De Pasquale M, Allos T, McMunn C, D'Aquila RT.

Virology. 2012 Aug 15;430(1):1-9. doi: 10.1016/j.virol.2012.03.018. Epub 2012 May 12.

9.
10.

The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict.

Compton AA, Hirsch VM, Emerman M.

Cell Host Microbe. 2012 Jan 19;11(1):91-8. doi: 10.1016/j.chom.2011.11.010.

11.

Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.

Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT.

J Virol. 2008 Oct;82(20):9928-36. doi: 10.1128/JVI.01017-08. Epub 2008 Aug 6.

12.

The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model.

Cadena C, Stavrou S, Manzoni T, Iyer SS, Bibollet-Ruche F, Zhang W, Hahn BH, Browne EP, Ross SR.

Retrovirology. 2016 Jun 30;13(1):45. doi: 10.1186/s12977-016-0280-y.

13.

Interaction between HIV-1 and APOBEC3 sub-family of proteins.

Arriaga ME, Carr J, Li P, Wang B, Saksena NK.

Curr HIV Res. 2006 Oct;4(4):401-9. Review.

PMID:
17073615
14.

Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.

Schmitt K, Hill MS, Ruiz A, Culley N, Pinson DM, Wong SW, Stephens EB.

Virology. 2009 Jan 20;383(2):362-72. doi: 10.1016/j.virol.2008.10.013. Epub 2008 Nov 21.

15.
16.

Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.

Reddy K, Ooms M, Letko M, Garrett N, Simon V, Ndung'u T.

AIDS. 2016 Jul 17;30(11):1723-9. doi: 10.1097/QAD.0000000000001113.

18.

Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques.

Kinman L, Brodie SJ, Tsai CC, Bui T, Larsen K, Schmidt A, Anderson D, Morton WR, Hu SL, Ho RJ.

J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):387-97.

PMID:
14615656
19.

Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.

Mussil B, Sauermann U, Motzkus D, Stahl-Hennig C, Sopper S.

Retrovirology. 2011 Sep 28;8:77. doi: 10.1186/1742-4690-8-77.

20.

Rapid shift from virally infected cells to germinal center-retained virus after HIV-2 infection of macaques.

Eitner F, Cui Y, Grouard-Vogel G, Hudkins KL, Schmidt A, Birkebak T, Agy MB, Hu SL, Morton WR, Anderson DM, Clark EA, Alpers CE.

Am J Pathol. 2000 Apr;156(4):1197-207.

Supplemental Content

Support Center